Phase II trial of docetaxel in patients with stage III and IV non-small- cell lung cancer

Journal of Clinical Oncology

Volumn 12, Issue 6, 1994, Pages 1232-1237

  Francis, P A ^a   Rigas, J R ^a   Kris, M G ^a   Pisters, K M W ^a   Orazem, J P ^a   Woolley, K J ^a   Heelan, R T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PREMEDICATION; PRIORITY JOURNAL; RASH; SENSORY NEUROPATHY;

EID: 0028240902     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1994.12.6.1232     Document Type: Article

References (0)